Skip to main content

Table 5 Crude and Adjusted Odds Ratios for Four Outcomes in a Sample of CHF Patients with Only One Record per Patient*: Nesiritide compared to No Nesiritide (n = 18,195 unique patients)

From: Outcomes of patients hospitalized for acute decompensated heart failure: does nesiritide make a difference?

 

Outcome

Type of odds ratio

Hospital mortality OR (95% CI)

Prolonged length of stay OR (95% CI)

Elevated pharmacy cost OR (95% CI)

Readmission within 31 days for cardiac condition other than CHF OR (95% CI)

Unadjusted

1.48 (1.14–1.93)

2.51 (2.26–2.79)

6.82 (6.12–7.61)

1.25 (1.05–1.49)

Adjusted for 9 medications**

1.23 (0.91–1.65)

1.97 (1.76–2.20)

5.78 (5.15–6.48)

1.25 (1.05–1.49)

Adjusted for APR-DRG severity of illness score

0.87 (0.66–1.15)

1.97 (1.76–2.22)

6.60 (5.85–7.43)

1.26 (1.06–1.50)

Adjusted for 9 medications, APR-DRG severity of illness score, race, and low economic status

0.98 (0.72–1.34)

1.65 (1.46–1.86)

5.66 (5.01–6.40)

1.25 (1.04–1.49)

Adjusted for APR-DRG risk of mortality score

0.89 (0.68–1.18)

N/A

N/A

N/A

Adjusted for APR-DRG risk of mortality score, 9 medications, race, and low economic status

1.01 (0.74–1.37)

N/A

N/A

N/A

  1. * This sample excluded the subsequent records of patients who were admitted multiple times for CHF during the study period
  2. ** Listed in Table 1
  3. † OR = odds ratio
  4. ‡ CI = confidence interval